Sentences 4 & 5 read: “An OCD sufferer himself, Barber spent a decade working in places like New York City’s Bellevue Hospital. He knew something was wrong when he discovered that his colleagues’ perfectly functional, $300-an-hour Upper West Side clients were taking the same potent pills as his own schizoid, homeless, crackhead patients. “I would spend part of the day in shelters dealing with seriously ill people,” Barber says. ‘Then I’d go to cocktail parties and find out that the people there were on the same medications.'”
http://www.wired.com/culture/culturereviews/magazine/16-02/pl_print
By Josh McHughes
01.18.08 | 6:00 PM (from New York Times)
Sometime in the 1990s, the concept of better living through chemistry turned a corner, thanks to drug companies’ efforts to synthesize antidotes for every possible mood swing. So writes Yale lecturer Charles Barber in his new book, Comfortably Numb: How Psychiatry Is Medicating a Nation. An OCD sufferer himself, Barber spent a decade working in places like New York City’s Bellevue Hospital. He knew something was wrong when he discovered that his colleagues’ perfectly functional, $300-an-hour Upper West Side clients were taking the same potent pills as his own schizoid, homeless, crackhead patients. “I would spend part of the day in shelters dealing with seriously ill people,” Barber says. “Then I’d go to cocktail parties and find out that the people there were on the same medications.” He proposes that we just say no to multinational drug peddlers and heal ourselves with cognitive and dialectical behavioral therapies “talk therapy” techniques that minimize pill pushing, dispense with Freudian dream analysis, and engage patients in actively reprogramming their own brains. It’s like “a highly selective carpentry of the soul,” Barber writes therapy as self-engineering.
He does acknowledge the need for medication in the hardest cases. Just like cancer, severe mood disorders can be life-threatening and should be treated as such, Barber says. But we need to distinguish between real depression and just being bummed out.
The vast majority of the 227 million prescriptions for antidepressants in 2006, he notes, were for people in the second category. Barber lambastes the drug industry for its attempt to turn “the worried well” into customers; he also takes aim at the Diagnostic and Statistical Manual of Mental Disorders for according disorder status to conditions like social anxiety and adjusting to a cross-country move. “Nonsense,” Barber writes, “anger, greed, laziness, impulsivity, as well as jealousy, lust, anguish, and so on, are simply part of the human predicament. They are not medical conditions.”